{"transactions":[{"id":1683643,"issuer":{"id":1487,"kind":"organization","name":"LeonaBio, Inc.","symbol":"LONA"},"owners":[{"id":95367,"kind":"person","name":"MOEBIUS HANS","position":1,"cik":"0001822494","reported_name":"MOEBIUS HANS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-01-08T21:45:00.000Z","date":"2024-01-04","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"On November 3, 2021, the reporting person was granted restricted stock units (\"RSUs\") representing 30,000 shares of Common Stock of the Issuer. The RSUs are scheduled to vest according to the following amended vesting schedule: (1) one third (1/3rd) of the number of shares subject to the RSU award vest at the completion of the public readout of topline results of the Issuer's ACT-AD Phase 2 clinical trial; (2) one third (1/3rd) of the number of shares subject to the RSU award vest as of the date the Compensation Committee (the \"Committee\") determines that enrollment of the Company's LIFT-AD Phase 2/3 clinical trial has been completed, and (3) one third (1/3rd) of the number of shares subject to the RSU award vest as of the completion of the public readout of topline results of the Issuer's LIFT-AD Phase 2/3 clinical trial (the \"LIFT-AD Readout\"), in each case subject to continued service with the Issuer through the applicable vesting date."},{"field":"shares","element":"transactionShares","label":"F2","text":"On January 4, 2023, the Committee determined that enrollment of the Company's LIFT-AD Phase 2/3 clinical trial had been completed and 10,000 RSUs vested and settled on such date."}],"balance_after":91482,"source":{"system":"sec-edgar","filing":"0001209191-24-001157","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1620463/000120919124001157/doc4.xml","form_type":"4"}},{"id":1864847,"issuer":{"id":1487,"kind":"organization","name":"LeonaBio, Inc.","symbol":"LONA"},"owners":[{"id":95367,"kind":"person","name":"MOEBIUS HANS","position":1,"cik":"0001822494","reported_name":"MOEBIUS HANS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-06T23:35:12.000Z","date":"2023-06-02","kind":"exercise","planned":false,"acquired":false,"shares":7882,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"One-fourth of the shares subject to the option vested on June 1, 2020 and one-fourth of the shares subject to the option vest on each year thereafter."}],"balance_after":0,"derivative":{"exercise_price":1.35,"expiration_date":"2029-08-14","underlying":"Common Stock","underlying_shares":7882},"source":{"system":"sec-edgar","filing":"0001209191-23-034886","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1620463/000120919123034886/doc4.xml","form_type":"4"}},{"id":1864846,"issuer":{"id":1487,"kind":"organization","name":"LeonaBio, Inc.","symbol":"LONA"},"owners":[{"id":95367,"kind":"person","name":"MOEBIUS HANS","position":1,"cik":"0001822494","reported_name":"MOEBIUS HANS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-06-06T23:35:12.000Z","date":"2023-06-02","kind":"exercise","planned":false,"acquired":true,"shares":7882,"price":1.35,"value":10640.7,"ownership":{"direct":true},"balance_after":81482,"source":{"system":"sec-edgar","filing":"0001209191-23-034886","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1620463/000120919123034886/doc4.xml","form_type":"4"}},{"id":1864845,"issuer":{"id":1487,"kind":"organization","name":"LeonaBio, Inc.","symbol":"LONA"},"owners":[{"id":95367,"kind":"person","name":"MOEBIUS HANS","position":1,"cik":"0001822494","reported_name":"MOEBIUS HANS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-06-06T23:35:12.000Z","date":"2023-05-18","kind":"grant","planned":false,"acquired":true,"shares":7764,"price":2.41,"value":18711.24,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The reporting person is voluntarily reporting the acquisition of shares of the issuer's common stock pursuant to the Athira Pharma, Inc. 2020 Employee Stock Purchase Plan (\"ESPP\"), for the ESPP Purchase Period (as defined in the ESPP) of November 18, 2022 through May 18, 2023. This transaction is also exempt under Rule 16b-3(c)."},{"field":"date","element":"transactionDate","label":"F2","text":"The Purchase Period ended May 18, 2023 and is the Purchase Period comprising the Offering Period (as defined in the ESPP) that began November 18, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"In accordance with the ESPP, these shares were purchased based on 85% of the closing price on May 18, 2023."}],"balance_after":73600,"source":{"system":"sec-edgar","filing":"0001209191-23-034886","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1620463/000120919123034886/doc4.xml","form_type":"4"}},{"id":2048409,"issuer":{"id":1487,"kind":"organization","name":"LeonaBio, Inc.","symbol":"LONA"},"owners":[{"id":95367,"kind":"person","name":"MOEBIUS HANS","position":1,"cik":"0001822494","reported_name":"MOEBIUS HANS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-23T22:53:21.000Z","date":"2023-01-19","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One thirty-sixth (1/36th) of the shares subject to the option will vest on February 19, 2023 and one thirty-sixth of the shares subject to the option will vest each month thereafter."}],"balance_after":200000,"derivative":{"exercise_price":3.37,"expiration_date":"2033-01-18","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001209191-23-004480","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1620463/000120919123004480/doc4.xml","form_type":"4"}},{"id":2111519,"issuer":{"id":1487,"kind":"organization","name":"LeonaBio, Inc.","symbol":"LONA"},"owners":[{"id":95367,"kind":"person","name":"MOEBIUS HANS","position":1,"cik":"0001822494","reported_name":"MOEBIUS HANS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-11-18T00:10:32.000Z","date":"2022-11-15","kind":"purchase","acquired":true,"shares":5000,"price":3.2884,"value":16442.0,"ownership":{"direct":true},"balance_after":65836,"source":{"system":"sec-edgar","filing":"0001209191-22-057721","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1620463/000120919122057721/doc4.xml","form_type":"4"}},{"id":2136151,"issuer":{"id":1487,"kind":"organization","name":"LeonaBio, Inc.","symbol":"LONA"},"owners":[{"id":95367,"kind":"person","name":"MOEBIUS HANS","position":1,"cik":"0001822494","reported_name":"MOEBIUS HANS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-10-17T22:06:59.000Z","date":"2022-10-13","kind":"exercise","acquired":false,"shares":7881,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-fourth of the shares subject to the option vested on June 1, 2020 and one-fourth of the shares subject to the option vest on each year thereafter."}],"balance_after":7882,"derivative":{"exercise_price":1.35,"expiration_date":"2029-08-14","underlying":"Common Stock","underlying_shares":7881},"source":{"system":"sec-edgar","filing":"0001209191-22-053869","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1620463/000120919122053869/doc4.xml","form_type":"4"}},{"id":2136150,"issuer":{"id":1487,"kind":"organization","name":"LeonaBio, Inc.","symbol":"LONA"},"owners":[{"id":95367,"kind":"person","name":"MOEBIUS HANS","position":1,"cik":"0001822494","reported_name":"MOEBIUS HANS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-10-17T22:06:59.000Z","date":"2022-10-13","kind":"exercise","acquired":true,"shares":7881,"price":1.35,"value":10639.35,"ownership":{"direct":true},"balance_after":60836,"source":{"system":"sec-edgar","filing":"0001209191-22-053869","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1620463/000120919122053869/doc4.xml","form_type":"4"}},{"id":2218477,"issuer":{"id":1487,"kind":"organization","name":"LeonaBio, Inc.","symbol":"LONA"},"owners":[{"id":95367,"kind":"person","name":"MOEBIUS HANS","position":1,"cik":"0001822494","reported_name":"MOEBIUS HANS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-06-30T21:00:03.000Z","date":"2022-06-28","kind":"purchase","acquired":true,"shares":10000,"price":2.88,"value":28800.0,"ownership":{"direct":true},"balance_after":52955,"source":{"system":"sec-edgar","filing":"0001209191-22-039937","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1620463/000120919122039937/doc4.xml","form_type":"4"}},{"id":2221778,"issuer":{"id":1487,"kind":"organization","name":"LeonaBio, Inc.","symbol":"LONA"},"owners":[{"id":95367,"kind":"person","name":"MOEBIUS HANS","position":1,"cik":"0001822494","reported_name":"MOEBIUS HANS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-06-24T23:54:04.000Z","date":"2022-06-22","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"On November 3, 2021, the reporting person was granted restricted stock units (\"RSUs\") representing 30,000 shares of Common Stock of the Issuer. The RSUs were scheduled to vest according to the following schedule: (1) one third (1/3rd) of the number of shares subject to the RSU award vest at the completion of the public readout of topline results of the Issuer's ACT-AD Phase 2 clinical trial; (2) one third (1/3rd) of the number of shares subject to the RSU award vest at the completion of the public readout of topline results of the Issuer's LIFT-AD Phase 2/3 clinical trial (the \"LIFT-AD Readout\") and (3) one third (1/3rd) of the number of shares subject to the RSU award vest six (6) months after the LIFT-AD Readout, in each case subject to continued service with the Issuer through the applicable vesting date. On June 22, 2022, the Issuer completed the public readout of topline results of the ACT-AD Phase 2 clinical trial and 10,000 RSUs vested and settled on such date."}],"balance_after":42955,"source":{"system":"sec-edgar","filing":"0001209191-22-039343","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1620463/000120919122039343/doc4.xml","form_type":"4"}},{"id":2221777,"issuer":{"id":1487,"kind":"organization","name":"LeonaBio, Inc.","symbol":"LONA"},"owners":[{"id":95367,"kind":"person","name":"MOEBIUS HANS","position":1,"cik":"0001822494","reported_name":"MOEBIUS HANS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-06-24T23:54:04.000Z","date":"2022-05-18","kind":"grant","acquired":true,"shares":1699,"price":7.06,"value":11994.94,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The reporting person is voluntarily reporting the acquisition of shares of the issuer's common stock pursuant to the Athira Pharma, Inc. 2020 Employee Stock Purchase Plan (\"ESPP\"), for the ESPP Purchase Period (as defined in the ESPP) of November 18, 2021 through May 18, 2022. This transaction is also exempt under Rule 16b-3(c)."},{"field":"date","element":"transactionDate","label":"F2","text":"The Purchase Period ended May 18, 2022 and is the Purchase Period comprising the Offering Period (as defined in the ESPP) that began November 18, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"In accordance with the ESPP, these shares were purchased based on 85% of the closing price on May 18, 2022."}],"balance_after":32955,"source":{"system":"sec-edgar","filing":"0001209191-22-039343","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1620463/000120919122039343/doc4.xml","form_type":"4"}},{"id":2429677,"issuer":{"id":1487,"kind":"organization","name":"LeonaBio, Inc.","symbol":"LONA"},"owners":[{"id":95367,"kind":"person","name":"MOEBIUS HANS","position":1,"cik":"0001822494","reported_name":"MOEBIUS HANS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-20T22:25:42.000Z","date":"2022-01-18","kind":"grant","acquired":true,"shares":180000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"One forty-eighth (1/48th) of the shares subject to the option will vest on February 18, 2022, and one forty-eighth of the shares subject to the option will vest each month thereafter."}],"balance_after":180000,"derivative":{"exercise_price":10.64,"expiration_date":"2032-01-17","underlying":"Common Stock","underlying_shares":180000},"source":{"system":"sec-edgar","filing":"0001209191-22-004120","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1620463/000120919122004120/doc4.xml","form_type":"4"}},{"id":2429676,"issuer":{"id":1487,"kind":"organization","name":"LeonaBio, Inc.","symbol":"LONA"},"owners":[{"id":95367,"kind":"person","name":"MOEBIUS HANS","position":1,"cik":"0001822494","reported_name":"MOEBIUS HANS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-01-20T22:25:42.000Z","date":"2021-11-18","kind":"grant","acquired":true,"shares":829,"price":12.51,"value":10370.79,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The reporting person is voluntarily reporting the acquisition of shares of the issuer's common stock pursuant to the Athira Pharma, Inc. 2020 Employee Stock Purchase Plan (\"ESPP\"), for the ESPP Purchase Period (as defined in the ESPP) of May 18, 2021 through November 18, 2021. This transaction is also exempt under Rule 16b-3(c)."},{"field":"date","element":"transactionDate","label":"F2","text":"The Purchase Period ended November 18, 2021 and is the Purchase Period comprising the Offering Period (as defined in the ESPP) that began May 18, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"In accordance with the ESPP, these shares were purchased based on 85% of the closing price on November 18, 2021."}],"balance_after":31256,"source":{"system":"sec-edgar","filing":"0001209191-22-004120","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1620463/000120919122004120/doc4.xml","form_type":"4"}},{"id":2627880,"issuer":{"id":1487,"kind":"organization","name":"LeonaBio, Inc.","symbol":"LONA"},"owners":[{"id":95367,"kind":"person","name":"MOEBIUS HANS","position":1,"cik":"0001822494","reported_name":"MOEBIUS HANS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-07-21T20:47:31.000Z","date":"2021-07-21","kind":"exercise","acquired":false,"shares":15762,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"One-fourth of the shares subject to the option vested on June 1, 2020 and one-fourth of the shares subject to the option vest on each year thereafter."}],"balance_after":15763,"derivative":{"exercise_price":1.35,"expiration_date":"2029-08-14","underlying":"Common Stock","underlying_shares":15762},"source":{"system":"sec-edgar","filing":"0001209191-21-047601","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1620463/000120919121047601/doc4.xml","form_type":"4"}},{"id":2627879,"issuer":{"id":1487,"kind":"organization","name":"LeonaBio, Inc.","symbol":"LONA"},"owners":[{"id":95367,"kind":"person","name":"MOEBIUS HANS","position":1,"cik":"0001822494","reported_name":"MOEBIUS HANS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-07-21T20:47:31.000Z","date":"2021-07-21","kind":"exercise","acquired":false,"shares":12610,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to the option fully vested on April 1, 2021."}],"balance_after":0,"derivative":{"exercise_price":1.35,"expiration_date":"2029-06-25","underlying":"Common Stock","underlying_shares":12610},"source":{"system":"sec-edgar","filing":"0001209191-21-047601","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1620463/000120919121047601/doc4.xml","form_type":"4"}},{"id":2627878,"issuer":{"id":1487,"kind":"organization","name":"LeonaBio, Inc.","symbol":"LONA"},"owners":[{"id":95367,"kind":"person","name":"MOEBIUS HANS","position":1,"cik":"0001822494","reported_name":"MOEBIUS HANS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-07-21T20:47:31.000Z","date":"2021-07-21","kind":"exercise","acquired":true,"shares":15762,"price":1.35,"value":21278.7,"ownership":{"direct":true},"balance_after":30427,"source":{"system":"sec-edgar","filing":"0001209191-21-047601","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1620463/000120919121047601/doc4.xml","form_type":"4"}},{"id":2627877,"issuer":{"id":1487,"kind":"organization","name":"LeonaBio, Inc.","symbol":"LONA"},"owners":[{"id":95367,"kind":"person","name":"MOEBIUS HANS","position":1,"cik":"0001822494","reported_name":"MOEBIUS HANS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-07-21T20:47:31.000Z","date":"2021-07-21","kind":"exercise","acquired":true,"shares":12610,"price":1.35,"value":17023.5,"ownership":{"direct":true},"balance_after":14665,"source":{"system":"sec-edgar","filing":"0001209191-21-047601","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1620463/000120919121047601/doc4.xml","form_type":"4"}},{"id":2627876,"issuer":{"id":1487,"kind":"organization","name":"LeonaBio, Inc.","symbol":"LONA"},"owners":[{"id":95367,"kind":"person","name":"MOEBIUS HANS","position":1,"cik":"0001822494","reported_name":"MOEBIUS HANS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-07-21T20:47:31.000Z","date":"2021-05-18","kind":"grant","acquired":true,"shares":2055,"price":14.45,"value":29694.75,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The reporting person is voluntarily reporting the acquisition of shares of the issuer's common stock pursuant to the Athira Pharma, Inc. 2020 Employee Stock Purchase Plan (\"ESPP\"), for the ESPP Purchase Period (as defined in the ESPP) of September 17, 2020 through May 18, 2021. This transaction is also exempt under Rule 16b-3(c)."},{"field":"date","element":"transactionDate","label":"F2","text":"The Purchase Period ended May 18, 2021 and is the Purchase Period comprising the Offering Period (as defined in the ESPP) that began September 17, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the initial public offering price from the issuer's initial public offering."}],"balance_after":2055,"source":{"system":"sec-edgar","filing":"0001209191-21-047601","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1620463/000120919121047601/doc4.xml","form_type":"4"}},{"id":2842640,"issuer":{"id":1487,"kind":"organization","name":"LeonaBio, Inc.","symbol":"LONA"},"owners":[{"id":95367,"kind":"person","name":"MOEBIUS HANS","position":1,"cik":"0001822494","reported_name":"MOEBIUS HANS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-22T22:39:40.000Z","date":"2021-02-18","kind":"grant","acquired":true,"shares":72000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-fourth of the shares subject to the option will vest on January 8, 2022, and one-fourth of the shares subject to the option will vest on each year thereafter."}],"balance_after":72000,"derivative":{"exercise_price":21.15,"expiration_date":"2031-02-17","underlying":"Common Stock","underlying_shares":72000},"source":{"system":"sec-edgar","filing":"0001209191-21-012823","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1620463/000120919121012823/doc4.xml","form_type":"4"}}]}